Key result
Caprini VTE risk protocol proves safe in thoracic surgery, yielding a 2.3% overall VTE rate.
Why the study?
Venous thromboembolism is a serious postoperative complication with many events occurring post-discharge, and the Caprini VTE risk assessment model had not been prospectively implemented and evaluated in thoracic surgical patients.
Does the implementation of a Caprini VTE risk assessment protocol prevent VTE safely in thoracic surgical patients?
Cohort (n=126)
No
Does the implementation of a Caprini VTE risk assessment protocol prevent VTE safely in thoracic surgical patients?
Implementation of the Caprini VTE risk assessment protocol with extended enoxaparin prophylaxis in high-risk thoracic surgical patients is safe, feasible, and associated with high adherence and low VTE rates.
High adherence with no post-discharge VTEs or bleeding supports feasibility in thoracic surgery; leaves open whether extended prophylaxis reduces events versus usual care.
BACKGROUND: Venous thromboembolism (VTE) can be a devastating postoperative complication, with about one-third of VTEs occurring post-discharge. We previously retrospectively evaluated the Caprini VTE risk assessment model (RAM) in postoperative lung and esophageal cancer patients, demonstrating that "high risk" patients were more likely to have a postoperative VTE. In this study, we sought to implement the RAM protocol in thoracic surgical patients to evaluate adherence, safety, and VTE outcomes. STUDY DESIGN: This prospective cohort study at a large safety net hospital included all surgically treated patients within the thoracic surgery division beginning in July 2014. Per RAM protocol, patients with high risk scores were prescribed a total of 30 days of postoperative daily enoxaparin prophylaxis, and moderate risk patients received a total of 10 postoperative days. Adherence and outcome audits were conducted. RESULTS: A total of 126 patients were included for analysis. Provider adherence to RAM score calculation was 99.2% (125 of 126), with appropriate post-discharge prophylaxis prescribed in 96.0% of cases. Twenty-four patients scored high risk (19.2%), 60 were moderate risk (48.0%), and 41 scored low risk (32.8%). Patient adherence to post-discharge enoxaparin prophylaxis was 97.2%. The overall VTE rate was 2.3%, with no post-discharge VTEs or adverse bleeding events. CONCLUSIONS: Implementation of a VTE risk assessment protocol with extended course prophylaxis in high risk patients is safe and feasible for providers and thoracic surgical patients at a large safety net institution with a diverse patient population. Follow-up studies are needed to assess efficacy of the RAM in this surgical population.
No takes yet. Share an insight, caveat, or question.
Hachey et al. (2015) conducted a cohort in Postoperative thoracic surgery (n=126). Caprini VTE risk assessment protocol was evaluated on Overall VTE rate. Implementation of the Caprini VTE risk assessment protocol in thoracic surgical patients was safe and feasible, yielding an overall VTE rate of 2.3% with no post-discharge VTEs or bleeding events.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: